Literature DB >> 11862526

Active vitamin D and its analogs as drugs for the treatment of osteoporosis: advantages and problems.

Yasuho Nishii1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11862526     DOI： 10.1007/s007740200008

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN： 0914-8779            Impact factor:   2.626


× No keyword cloud information.
  4 in total

Review 1.  Treatment of osteoporosis with eldecalcitol, a new vitamin D analog: a comprehensive review and meta-analysis of randomized clinical trials.

Authors:  Zhixing Xu; Changchun Fan; Xuechun Zhao; Hairong Tao
Journal:  Drug Des Devel Ther       Date:  2016-01-28       Impact factor: 4.162

Review 2.  Vitamin D, disease and therapeutic opportunities.

Authors:  Lori A Plum; Hector F DeLuca
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

3.  Eldecalcitol effects on osteoblastic differentiation and function in the presence or absence of osteoclastic bone resorption.

Authors:  Jie Bu; Juan Du; Lina Shi; Wei Feng; Wei Wang; Jie Guo; Tomoka Hasegawa; Hongrui Liu; Xuxia Wang; Minqi Li
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

Review 4.  A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol.

Authors:  Noboru Kubodera
Journal:  Molecules       Date:  2009-09-29       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.